Bank of America’s Rigel Pharmaceuticals RIGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $2.14M | Sell |
|
|||||
|
2025
Q2 | $3.51M | Buy |
|
|||||
|
2025
Q1 | $2.38M | Buy |
|
|||||
|
2024
Q4 | $541K | Buy |
|
|||||
|
2024
Q3 | $463K | Buy |
|
|||||
|
2024
Q2 | $139K | Buy |
|
|||||
|
2024
Q1 | $166K | Sell |
|
|||||
|
2023
Q4 | $247K | Buy |
|
|||||
|
2023
Q3 | $106K | Buy |
|
|||||
|
2023
Q2 | $122K | Sell |
|
|||||
|
2023
Q1 | $219K | Sell |
|
|||||
|
2022
Q4 | $277K | Sell |
|
|||||
|
2022
Q3 | $356K | Sell |
|
|||||
|
2022
Q2 | $1.27M | Buy |
|
|||||
|
2022
Q1 | $822K | Buy |
|
|||||
|
2021
Q4 | $663K | Sell |
|
|||||
|
2021
Q3 | $1.09M | Buy |
|
|||||
|
2021
Q2 | $1.29M | Buy |
|
|||||
|
2021
Q1 | $754K | Buy |
|
|||||
|
2020
Q4 | $92K | Sell |
|
|||||
|
2020
Q3 | $86K | Sell |
|
|||||
|
2020
Q2 | $121K | Buy |
|
|||||
|
2020
Q1 | $78K | Sell |
|
|||||
|
2019
Q4 | $140K | Sell |
|
|||||
|
2019
Q3 | $197K | Sell |
|
|||||
|
2019
Q2 | $621K | Sell |
|
|||||
|
2019
Q1 | $2.77M | Buy |
|
|||||
|
2018
Q4 | $1.35M | Buy |
|
|||||
|
2018
Q3 | $135K | Sell |
|
|||||
|
2018
Q2 | $950K | Buy |
|
|||||
|
2018
Q1 | $1.05M | Buy |
|
|||||
|
2017
Q4 | $198K | Buy |
|
|||||
|
2017
Q3 | $121K | Buy |
|
|||||
|
2017
Q2 | $79K | Sell |
|
|||||
|
2017
Q1 | $365K | Sell |
|
|||||
|
2016
Q4 | $850K | Buy |
|
|||||
|
2016
Q3 | $559K | Buy |
|
|||||
|
2016
Q2 | $53K | Buy |
|
|||||
|
2016
Q1 | $22K | Sell |
|
|||||
|
2015
Q4 | $85K | Buy |
|
|||||
|
2015
Q3 | $8K | Sell |
|
|||||
|
2015
Q2 | $17K | Buy |
|
|||||
|
2015
Q1 | $8K | Buy |
|
|||||
|
2014
Q4 | $1K | Sell |
|
|||||
|
2014
Q3 | $124K | Buy |
|
|||||
|
2014
Q2 | $129K | Buy |
|
|||||
|
2014
Q1 | $129K | Sell |
|
|||||
|
2013
Q4 | $397K | Buy |
|
|||||
|
2013
Q3 | $215K | Buy |
|
|||||
|
2013
Q2 | $170K | Buy |
|